BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARγ/PDK1 dependent manner-Reference-Cited by-同舟云学术

BEX1 supports the stemness of hepatoblastoma by facilitating Warburg effect in a PPARγ/PDK1 dependent manner

Published:2023-09-15 Issue:9 Volume:129 Page:1477-1489
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Wang Qian,Liang Ning,Liu Chaoxu,Li Jing,Bai Yaxing,Lei Shuanghong,Huang Qian,Sun Ligang,Tang Liangke,Zeng Chao,Tang Yuqun,He Xianli,Yang Tao,Wang Gang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-023-02418-4.pdf

Reference93 articles.

1. Sumazin P, Peters TL, Sarabia SF, Kim HR, Urbicain M, Hollingsworth EF, et al. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022;77:1026–37.

2. Trobaugh-Lotrario A, Katzenstein HM, Ranganathan S, Lopez-Terrada D, Krailo MD, Piao J, et al. Small cell undifferentiated histology does not adversely affect outcome in hepatoblastoma: a report from the children’s oncology group (COG) AHEP0731 study committee. J Clin Oncol. 2022;40:459–67.

3. Loesch R, Caruso S, Paradis V, Godard C, Gougelet A, Renault G, et al. Deleting the beta-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumour growth. J Hepatol. 2022;77:424–35.

4. Semeraro M, Branchereau S, Maibach R, Zsiros J, Casanova M, Brock P, et al. Relapses in hepatoblastoma patients: clinical characteristics and outcome–experience of the International Childhood Liver Tumour Strategy Group (SIOPEL). Eur J Cancer. 2013;49:915–22.

5. Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol. 2000;1:94–100.